Two Cancer Bills Introduced in the US House of Representatives

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 15 No 7
Volume 15
Issue 7

This new department summarizes current congressional activity relevant to the delivery of cancer care. Two bills recently introduced in the House of Representatives are designed to improve the quality of care for cancer patients on the Medicare program.

This new department summarizes current congressional activity relevant to the delivery of cancer care. Two bills recently introduced in the House of Representatives are designed to improve the quality of care for cancer patients on the Medicare program.

Comprehensive Cancer Care Improvement Act of 2006

Reps. Lois Capps (D-CA) and Tom Davis (R-VA) introduced HR 5465, "to amend title XVIII of the Social Security Act to provide for coverage of comprehensive cancer care planning under the Medicare Program and to improve the care furnished to individuals diagnosed with cancer by establishing a Medicare hospice care demonstration program and grants programs for cancer palliative care and symptom management programs, provider education, and related research."

Of primary interest to oncologists is that HR 5465 would establish a new Medicare service for the development of:

•A treatment plan at the beginning of primary therapy and communication of the plan to the patient

•A cancer care summary and follow-up care plan at the end of primary therapy and communication of it to the patient.

The legislation, supported by the National Coalition for Cancer Survivorship (NCCS), other national patient advocacy groups, and many US cancer centers, also includes provisions to improve symptom management and palliative care for patients undergoing cancer treatment.

Medicare Early Detection of Cancer Promotion Act of 2006

HR 5437, introduced by Rep. Clay Shaw (R-FL), would eliminate coinsurance payments for mammograms and colorectal screenings for Medicare beneficiaries. Currently, Medicare provides coverage for breast, cervical, colon and prostate cancer screening tests, for which the beneficiaries must provide a 20% co-payment.

The bill would amend title XVIII of the Social Security Act to extend for 6 months the eligibility period for the "Welcome to Medicare" physical examination and to eliminate coinsurance for screening mammography and colorectal cancer screening tests in order to promote the early detection of cancer."

The legislation, supported by the American Cancer Society (ACS), also would extend the availability of the "Welcome to Medicare" physical for new beneficiaries from 6 months to 1 year for the next 5 years.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Specialties including neurosurgery, radiation oncology, and neuro-rehabilitation all play a notable role in the care of patients with brain tumors.
Treatment-related toxicities during neuro-oncology therapy appear well managed with dose modifications and treatment cycle holds.
The phase 3 NIVOSTOP trial evaluated an anti–PD-1 immunotherapy, nivolumab, in a patient population similar in the KEYNOTE-689 trial.
CAR T-cell therapies appear to be an evolving modality in the treatment of those with intracranial tumors, said Sylvia Kurz, MD, PhD.
Opportunities to further reduce relapses include pembrolizumab-based combination therapy and evaluating the agent’s contribution before and after surgery.
For patients with locally advanced head and neck cancers, the current standard of care for curative therapy has a cure rate of less than 50%.
According to Maurie Markman, MD, patient-reported outcomes pertain to more relevant questions surrounding the impact of therapy for patients.
CancerNetwork® spoke with Neha Mehta-Shah, MD, MSCI, about the clinical landscape for patients undergoing treatment for rare lymphomas.
Related Content